No elevated risk for stroke seen after COVID-19 bivalent vaccine receipt
Mar 20, 2024
No evidence was seen for an increased risk for stroke in one- to 21-day or 22- to 42-day windows compared with a 43- to 90-day window after the vaccine.
Many US seniors do not intend to vaccinate against RSV
Mar 13, 2024
The primary reasons for vaccine hesitancy include lack of necessity, concerns about side effects and safety, and lack of information.
2023 to 2024 seasonal influenza vaccine effective for reducing risk
Feb 29, 2024
Vaccine effectiveness against influenza-linked outpatient visits ranged from 33 to 49%, and against hospitalization it ranged from 41 to 44% among adults.
Employer COVID-19 vaccine mandates significantly increase uptake with little effect on staffing: study
By
Kimberly Bonvissuto
Aug 08, 2023
An employee mandate led to a “significant” increase in COVID-19 vaccine uptake with little effect on staffing in a multi-state network of continuing care retirement communities studied by researchers,...
Immunoglobulin G spike receptor binding domain antibody levels were similar after the primary series and booster dose.
Simultaneous flu vaccine, COVID-19 booster safe
Jul 21, 2022
Systemic reactions generally were mild and were slightly more likely among those receiving both vaccines compared with the COVID-19 mRNA booster alone.
Fourth dose of BNT162b2 offers protection against severe COVID-19
Apr 08, 2022
Protection against COVID-19 did not wane in six weeks after receipt of fourth dose of the Pfizer–BioNTech vaccine; protection against the infection waned.
Effectiveness of Ad26.COV2.S vaccine stable for six months
Mar 22, 2022
A single dose of the Johnson & Johnson vaccine was 74% and 81% effective for preventing COVID-19 infection and hospitalizations, respectively, in the U.S. before and during delta variant surge.
Vaccine rollout linked to drop in severe COVID-19 in dialysis patients
Feb 28, 2022
And patients on maintenance dialysis who received COVID-19 vaccination had decreasing antibody titers over time.
Vaccine effectiveness up after three COVID-19 vaccine doses
Feb 14, 2022
Vaccine effectiveness was lower during the omicron- versus the delta-predominant period at all time points; it waned with increasing time since vaccination.